OncoBay Clinical is a specialized small CRO that focuses on immuno-oncology and cell therapy, delivering tailored CRO solutions to global pharmaceutical and biotech firms aiming to progress their immuno-oncology product or device. A for-profit subsidiary of Moffitt Cancer Center, OncoBay integrates scientific knowledge, operational excellence, and comprehensive cell manufacturing capabilities. Centered on cellular therapy, efficient technology, a skilled site network, and an experienced professional team are the foundations of OncoBay's offerings.